MacroGenics Inc
F:M55
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MacroGenics Inc
F:M55
|
US |
|
T
|
Thomson Reuters Corp
NYSE:TRI
|
CA |
|
Intesa Sanpaolo SpA
F:IESJ
|
IT |
|
Q
|
Qiagen NV
F:QIA
|
NL |
|
Schibsted ASA
LSE:0MHM
|
NO |
|
A
|
AXA SA
BMV:AXAN
|
FR |
|
N
|
Newmont Corporation
XMUN:NMM
|
US |
|
Exxaro Resources Ltd
F:LCQ
|
ZA |
|
A
|
Aptiv PLC
XBER:D7A
|
IE |
|
E
|
Enbridge Inc
F:EN3
|
CA |
|
W
|
Walmart Inc
BMV:WMT
|
US |
|
K
|
KGHM Polska Miedz SA
XMUN:KGHA
|
PL |
|
C
|
Commerzbank AG
F:CBK
|
DE |
|
P
|
People's Insurance Company Group of China Ltd
F:PIR
|
CN |
|
S
|
Svenska Cellulosa SCA AB
XMUN:SCA
|
SE |
|
Frontdoor Inc
NASDAQ:FTDR
|
US |
|
Viomi Technology Co Ltd
NASDAQ:VIOT
|
CN |
|
N
|
Nomura Holdings Inc
OTC:NRSCF
|
JP |
|
P
|
Posco Holdings Inc
SWB:PKX
|
KR |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
CNB Financial Corp
F:44I
|
US |
Bankruptcy Probability
MacroGenics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
MacroGenics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
MacroGenics Inc
NASDAQ:MGNX
|
190.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
60.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
MacroGenics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, MacroGenics Inc has total debt of 70m USD. This includes both short-term (0 USD) and long-term (70m USD) debt.
You can find a full breakdown on its Balance Sheet.
